179 related articles for article (PubMed ID: 11349023)
1. Biological activity of a C-terminal fragment of Pasteurella multocida toxin.
Busch C; Orth J; Djouder N; Aktories K
Infect Immun; 2001 Jun; 69(6):3628-34. PubMed ID: 11349023
[TBL] [Abstract][Full Text] [Related]
2. Mutation of a putative ADP-ribosylation motif in the Pasteurella multocida toxin does not affect mitogenic activity.
Ward PN; Higgins TE; Murphy AC; Mullan PB; Rozengurt E; Lax AJ
FEBS Lett; 1994 Mar; 342(1):81-4. PubMed ID: 8143855
[TBL] [Abstract][Full Text] [Related]
3. Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus.
Wilson BA; Ponferrada VG; Vallance JE; Ho M
Infect Immun; 1999 Jan; 67(1):80-7. PubMed ID: 9864199
[TBL] [Abstract][Full Text] [Related]
4. Localization of functional domains of the mitogenic toxin of Pasteurella multocida.
Pullinger GD; Sowdhamini R; Lax AJ
Infect Immun; 2001 Dec; 69(12):7839-50. PubMed ID: 11705966
[TBL] [Abstract][Full Text] [Related]
5. Pasteurella multocida toxin, a potent mitogen, increases inositol 1,4,5-trisphosphate and mobilizes Ca2+ in Swiss 3T3 cells.
Staddon JM; Barker CJ; Murphy AC; Chanter N; Lax AJ; Michell RH; Rozengurt E
J Biol Chem; 1991 Mar; 266(8):4840-7. PubMed ID: 2002031
[TBL] [Abstract][Full Text] [Related]
6. The pasteurella multocida toxin interacts with signalling pathways to perturb cell growth and differentiation.
Lax AJ; Pullinger GD; Baldwin MR; Harmey D; Grigoriadis AE; Lakey JH
Int J Med Microbiol; 2004 Apr; 293(7-8):505-12. PubMed ID: 15149025
[TBL] [Abstract][Full Text] [Related]
7. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue.
Ward PN; Miles AJ; Sumner IG; Thomas LH; Lax AJ
Infect Immun; 1998 Dec; 66(12):5636-42. PubMed ID: 9826336
[TBL] [Abstract][Full Text] [Related]
8. Pasteurella multocida toxin-induced activation of RhoA is mediated via two families of G{alpha} proteins, G{alpha}q and G{alpha}12/13.
Orth JH; Lang S; Taniguchi M; Aktories K
J Biol Chem; 2005 Nov; 280(44):36701-7. PubMed ID: 16141214
[TBL] [Abstract][Full Text] [Related]
9. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin.
Orth JH; Blöcker D; Aktories K
Biochemistry; 2003 May; 42(17):4971-7. PubMed ID: 12718539
[TBL] [Abstract][Full Text] [Related]
10. Pasteurella multocida toxin is a potent inducer of anchorage-independent cell growth.
Higgins TE; Murphy AC; Staddon JM; Lax AJ; Rozengurt E
Proc Natl Acad Sci U S A; 1992 May; 89(10):4240-4. PubMed ID: 1584759
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.
Orth JH; Fester I; Siegert P; Weise M; Lanner U; Kamitani S; Tachibana T; Wilson BA; Schlosser A; Horiguchi Y; Aktories K
FASEB J; 2013 Feb; 27(2):832-42. PubMed ID: 23150526
[TBL] [Abstract][Full Text] [Related]
12. Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms.
Ohnishi T; Horiguchi Y; Masuda M; Sugimoto N; Matsuda M
J Vet Med Sci; 1998 Mar; 60(3):301-5. PubMed ID: 9560776
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Targets of
Banu A; Lax AJ; Grigoriadis AE
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326543
[TBL] [Abstract][Full Text] [Related]
14. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin.
Orth JH; Fester I; Preuss I; Agnoletto L; Wilson BA; Aktories K
J Biol Chem; 2008 Aug; 283(34):23288-94. PubMed ID: 18583341
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
Lee J; Woo HJ
J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of Pasteurella multocida toxin are mediated by Gq-dependent and -independent mechanisms. involvement of Gq but not G11.
Zywietz A; Gohla A; Schmelz M; Schultz G; Offermanns S
J Biol Chem; 2001 Feb; 276(6):3840-5. PubMed ID: 11062245
[TBL] [Abstract][Full Text] [Related]
17. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
Seo J; Lee S; Pyo H; Lee J; Kim T
Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
[TBL] [Abstract][Full Text] [Related]
18. Pasteurella multocida toxin is a mitogen for bone cells in primary culture.
Mullan PB; Lax AJ
Infect Immun; 1996 Mar; 64(3):959-65. PubMed ID: 8641807
[TBL] [Abstract][Full Text] [Related]
19. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs.
To H; Someno S; Nagai S
Am J Vet Res; 2005 Jan; 66(1):113-8. PubMed ID: 15691045
[TBL] [Abstract][Full Text] [Related]
20. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts.
Rozengurt E; Higgins T; Chanter N; Lax AJ; Staddon JM
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):123-7. PubMed ID: 2153282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
